Senior Executive Will Scale Advanced Analytics Offerings to New and Broader Markets

MCLEAN, VA – RxAnte, Inc. a healthcare improvement company with a new and innovative approach for improving medication use, announced today that Peter Aldrich has been appointed Senior Vice President, Product and Program Management. In this role, Mr. Aldrich will provide interdisciplinary leadership and direction to translate RxAnte’s patent-pending analytics capabilities into new systems, products and programs that transform population medication use.

“RxAnte has experienced tremendous growth since our launch,” said Josh Benner, President and CEO of RxAnte. “Our proven analytic technologies are enabling new, personalized approaches to helping people use their medicines more safely and effectively. Pete, with his experience in healthcare technology and business and technical operations, will play an essential role in the successful delivery of these products and programs,” Benner continued.

Pete Aldrich comments, “RxAnte’s analytic offerings have proven their value to a strong customer base who have benefited through more efficient medication adherence programs. Upcoming product developments will further extend our ability to improve medication outcomes and contain costs among a wide range of constituents.”

Mr. Aldrich brings a decade of leadership experience in strategy, organizational development, operations management and process engineering. Prior to joining RxAnte, Aldrich held senior executive positions with Health Dialog and Fidelity Investments. Aldrich holds his B.A. from Saint Anselm College and his MBA from Franklin Pierce College.


About RxAnte
RxAnte is a health care improvement company that targets, manages and evaluates medication management programs to improve outcomes and lower costs. The company’s patent-pending predictive analytics and decision support solutions turn ordinary claims data into actionable insights and smart recommendations that help health care organizations and the populations they serve use medications more effectively, improve outcomes and save costs. For more information, please visit